FR2085648A1 - Euglobulin fraction 'm' - for restoring specific and general bodily defence mechanisms - Google Patents

Euglobulin fraction 'm' - for restoring specific and general bodily defence mechanisms

Info

Publication number
FR2085648A1
FR2085648A1 FR7015032A FR7015032A FR2085648A1 FR 2085648 A1 FR2085648 A1 FR 2085648A1 FR 7015032 A FR7015032 A FR 7015032A FR 7015032 A FR7015032 A FR 7015032A FR 2085648 A1 FR2085648 A1 FR 2085648A1
Authority
FR
France
Prior art keywords
fraction
defence mechanisms
water
specific
euglobulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7015032A
Other languages
English (en)
French (fr)
Other versions
FR2085648B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7015032A priority Critical patent/FR2085648A1/fr
Publication of FR2085648A1 publication Critical patent/FR2085648A1/fr
Application granted granted Critical
Publication of FR2085648B1 publication Critical patent/FR2085648B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR7015032A 1970-04-24 1970-04-24 Euglobulin fraction 'm' - for restoring specific and general bodily defence mechanisms Granted FR2085648A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7015032A FR2085648A1 (en) 1970-04-24 1970-04-24 Euglobulin fraction 'm' - for restoring specific and general bodily defence mechanisms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7015032A FR2085648A1 (en) 1970-04-24 1970-04-24 Euglobulin fraction 'm' - for restoring specific and general bodily defence mechanisms

Publications (2)

Publication Number Publication Date
FR2085648A1 true FR2085648A1 (en) 1971-12-31
FR2085648B1 FR2085648B1 (enExample) 1973-06-08

Family

ID=9054553

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7015032A Granted FR2085648A1 (en) 1970-04-24 1970-04-24 Euglobulin fraction 'm' - for restoring specific and general bodily defence mechanisms

Country Status (1)

Country Link
FR (1) FR2085648A1 (enExample)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274351A (fr) * 1950-10-27 1961-10-27 Procédé de préparation des fractions dites <bata> (immunisante) et <mu> (sensibiliante) du sérum et produits conformes à ceux obtenus par ce procédé

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274351A (fr) * 1950-10-27 1961-10-27 Procédé de préparation des fractions dites <bata> (immunisante) et <mu> (sensibiliante) du sérum et produits conformes à ceux obtenus par ce procédé

Also Published As

Publication number Publication date
FR2085648B1 (enExample) 1973-06-08

Similar Documents

Publication Publication Date Title
EA200601575A1 (ru) Казеиновые пептиды и их терапевтическое применение
BR112021022503A2 (pt) Métodos de administração de anticorpo anti-cd38 para tratar mieloma múltiplo
WO2016090024A3 (en) Combination therapy for treatment of cancer
BR112019000201A2 (pt) compostos e seu uso na redução dos níveis de ácido úrico
Shojaeefar et al. The possible double‐edged sword effects of vitamin D on COVID‐19: A hypothesis
Anadani et al. Acute‐onset chronic inflammatory demyelinating polyneuropathy: an electrodiagnostic study
FR2085648A1 (en) Euglobulin fraction &#39;m&#39; - for restoring specific and general bodily defence mechanisms
WO2022184942A3 (en) Biomarkers
DE69636527D1 (de) Antigenes protein aus malassezia
FR928389A (fr) Dispositif pour la pratique thérapeutique, chirurgicale ou pour soins de beauté
NL167691C (nl) Werkwijze ter bereiding of vervaardiging van therapeutische preparaten ter verzachting en opheffing van pijnen van verschillende oorsprong, alsmede ter behandeling van reumatische, artritische en andere ontstekingsziekten, waarbij men een werkzame stof in een voor therapeutische toepassing geschikte toedieningsvorm brengt, alsmede een werkwijze voor het bereiden van imidazoolverbindingen en de farmaceutisch aanvaardbare additiezouten daarvan, geschikt voor toepassing bij deze werkwijze.
WO2014193269A4 (ru) Лекарственное средство на основе дииндолилметана и его применение для лечения гриппа и респираторных вирусных инфекций
FR126M (fr) Nouveau médicament notamment pour le traitement de l&#39;hyperlipémie post-prandiale ou chronique.
US2594418A (en) Salicylic acid salt of 8-(5&#39;-isopropylaminoamylamino)-6-methoxyquinoline
EP3834191C0 (en) DEVICE FOR SPEECH THERAPY, ADMINISTRATION OF INHALATION MEDICATIONS FOR TREATMENT OF OTITIS, SINUSITIS AND BAROTRAUMA
FR2117727A1 (en) Sodium naringine - for increasing capillary resistance and impermeability
SU100751A1 (ru) Способ лечени мышечных гипертоний
Brooks The Rationale of Malaria Therapy in Late Localized Syphilis with Particular Reference to General Paralysis of the Insane
Yokoyama Studies on the Antigenicity of Bacterial Polysaccharides Part 2: On the Relationship Between Precipitation by B. Proteus X19 Polysaccharide and Weil-Felix Reaction
FR1204M (fr) Nouveau médicament, notamment pour le traitement de l&#39;hyperlipémie chronique ou post-prandiale.
COHEN et al. The treatment of two cases of bronchial asthma with electroshock therapy
Ivanova TREATMENT OF CHRONIC EPSTEIN BARR VIRUS INFECTION IN CHILDREN
AU115980B2 (en) Preparation for the alleviation and curative treatment of tumorous and similar ailments
BE473165A (fr) Inhalateur pour soulager les affections respiratoires.
Middleton A Woman

Legal Events

Date Code Title Description
ST Notification of lapse